SciELO - Scientific Electronic Library Online

 
vol.68 issue2Study of association between genetic polymorphisms of phospholipase A2 enzymes and Alzheimer's diseaseValidation of the "Six Step Spot Test" for gait among patients with multiple sclerosis in Brazil author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Abstract

GRZESIUK, Anderson Kuntz et al. Homozygotic intronic GAA mutation in three siblings with late-onset Pompe's disease. Arq. Neuro-Psiquiatr. [online]. 2010, vol.68, n.2, pp. 194-197. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X2010000200008.

Pompe's disease (PD) is a metabolic myopathy caused by the accumulation of lysosomal glycogen, secondary to acid α-glucosidase (GAA) enzyme deficiency. Childhood and late-onset forms are described, differing by the age of onset and symptoms. In this study were analyzed affected siblings with Pompe's disease (PD) and their distinct clinical and pathological presentations. METHOD: Diagnosis was performed by the clinical presentation of limb-girdle dystrophies and respiratory compromise. Confirmatory diagnoses were conducted by muscle biopsy, GAA activity measurement and by GAA gene genotyping. RESULTS: The findings suggested muscular involvement due to GAA deficiency. GAA genotyping showed they are homozygous for the c.-32-3C>A mutation. CONCLUSION: Herein we reported a family where three out of five siblings were diagnosed with late-onset PD, although it is a rare metabolic disease inherited in an autossomal recessive manner. We emphasize the importance of including this presentation within the differential diagnoses of the limb-girdle dystrophies once enzyme replacement therapy is available.

Keywords : glycogen storage disease type II; mutation; Pompe disease.

        · abstract in Portuguese     · text in English     · pdf in English